Pf Magazine

Pf Magazine Supporting pharma, life sciences and health. Stay up to date on
The Pf Media site h

Pf Magazine brings pharma to life, providing our readership with fascinating insights into the pharmaceutical industry. Intelligent, entertaining, compelling and informative - Pf proudly combines the most vital news items, with captivating features, interviews and event reports.

The impact of EU pharmaceutical reform - Pf Media https://bit.ly/3KQBWMQ
19/06/2024

The impact of EU pharmaceutical reform - Pf Media https://bit.ly/3KQBWMQ

The conversation around the proposed EU pharmaceutical legislation and incoming HTA reform was held against the backdrop of the EU elections.

Go-to-market innovation in 2028: Essential disruption dimensions for thriving in the new European healthcare landscape -...
06/06/2024

Go-to-market innovation in 2028: Essential disruption dimensions for thriving in the new European healthcare landscape - Pf Media https://bit.ly/3RcqP4s

The European healthcare market is poised for significant disruption, with evolving consumer demands and new competitive forces.

06/06/2024

Go-to-market innovation in 2028: Essential disruption dimensions for thriving in the new European healthcare landscape - Pf Media https://bit.ly/3Vw2Mjm

Dare to be disruptive – how to model your European go to market strategy for success - Pf Media https://bit.ly/3ytkpat
15/05/2024

Dare to be disruptive – how to model your European go to market strategy for success - Pf Media https://bit.ly/3ytkpat

Nick Bartlett, Head of Consulting at Uniphar, shares key takeaways from his workshop at Reuters Pharma 2024 in Barcelona.

Novartis' leukaemia treatment to be made available on the NHS - Pf Media https://bit.ly/44qLjvz
02/05/2024

Novartis' leukaemia treatment to be made available on the NHS - Pf Media https://bit.ly/44qLjvz

NICE recommends personalised immunotherapy for children and young adults to fight a form of leukaemia be made available on the NHS.

NICE recommends new Novartis treatment for brain tumours - Pf Media https://bit.ly/44hxqQu
25/04/2024

NICE recommends new Novartis treatment for brain tumours - Pf Media https://bit.ly/44hxqQu

NICE recommends new Novartis treatment for children and young people in England and Wales, with an aggressive form of brain tumour.

Promising new treatment strategy for aggressive form of leukaemia - Pf Media https://bit.ly/4463eb5
18/04/2024

Promising new treatment strategy for aggressive form of leukaemia - Pf Media https://bit.ly/4463eb5

A promising treatment strategy for an aggressive type of leukaemia – Acute myeloid leukaemia (AML) – has been uncovered.

Address

Arlesey

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 4pm

Website

Alerts

Be the first to know and let us send you an email when Pf Magazine posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category

Our Story

We are PharmaField- Your home for the latest news, insight, events, job opportunities and developments in the pharmaceutical industry.

With our resources, you can keep up to date on your terms. Across print, web and socials, we have the information you need to keep your career ahead.

Pf Magazine brings pharma to life, providing our readership with insights into the pharmaceutical industry. Intelligent, entertaining, compelling and informative - Pf proudly combines the most vital news items, with captivating features, interviews and event reports.